Stone Pharmaceutical Group (01093.HK): Stone Pharmaceutical Innovation (300765.SZ) reported a net profit attributable to shareholders of approximately 1.261 billion yuan in the first half of the year, turning a profit from a loss year-on-year.

Zhuhai Finance APP news, Shiyao Group (01093.HK) announced Shiyao Innovation (300765.SZ) mid-term performance for 2026, with operating revenue of approximately 3.24 billion yuan, a year-on-year increase of 208.72%; net profit attributable to shareholders of the listed company was approximately 1.261 billion yuan, turning a loss into a profit year-on-year; basic earnings per share were 0.9056 yuan.